https://www.selleckchem.com/pr....oducts/telacebec-q20
ffect of SGLT2i in conjunction with anorexia and vomiting. It is crucial to counsel patients to stop SGLT2is when sick, especially if SARS-CoV-2 infection is suspected. The objective of this report is to highlight the possible but little-known association between coronavirus disease 2019 (COVID-19) and delayed onset of central hypocortisolism, which may be of significant clinical importance. We describe a patient who developed new-onset central hypocortisolism in the convalescent phase of mild COVID-19, which has not been previou